#Trade Shows & Events
Eventful and unforgettable, successfully concluding, SpaceGen looks forward to meeting you again!
Eventful and unforgettable, successfully concluding, SpaceGen looks forward to meeting you again!
As the year-end approaches once again, it marks the beginning of a new year. The annual cycle seems to quietly draw another circle in an imperceptible moment. At this year-end, unwilling to be mediocre, SpaceGen continues its relentless pace, actively participating in five academic conferences and presenting satisfactory achievements.
PART.1
The 9th National Advanced Academic Forum on Ultrastructure and Molecular Pathology organized by the Chinese Research Hospital Association and the 2023 Annual Academic Conference
To further promote the continuous innovation and development of ultrastructure and molecular pathology in China, the "9th National Advanced Academic Forum on Ultrastructure and Molecular Pathology," approved by the Chinese Research Hospital Association and organized by the Pathology Department of Southern Medical University Southern Hospital, was held in Guangzhou, Guangdong Province from December 1 to December 3, 2023. The conference focused on the latest research and applications in the field of ultrastructure and molecular pathology, as well as multidisciplinary diagnosis and treatment of neurological pathology. Renowned Chinese pathology experts and experts from related disciplines were invited to gather for both online and offline academic exchanges and lectures.
During the exhibition, the SpaceGen team attracted numerous pathology experts and industry peers, engaging in in-depth exchanges and discussions on the application of genetic sequencing technology and clinical genetic testing in pathology.
PART.2
Lymphoma Clinical Pathological Diagnosis New Progress Workshop and 2023 Annual Meeting of the Chinese Medical Association Lymphohematologic Diseases Group
In the winter of Pengcheng, flowers bloom like the sea, and enthusiasts gather to discuss lymphoma. Organized by the Pathology Department of Peking University Shenzhen Hospital, the "Lymphoma Clinical Pathological Diagnosis New Progress Workshop" was held from December 8 to 10, 2023, at the Yinhui Conference Center in Shenzhen, Guangdong Province. The conference featured lectures by Professor Chen Guozhang and Professor Zhuo Hua from Elizabeth Hospital in Hong Kong, focusing closely on the latest version (2023) of the WHO classification of lymphohematopoietic tumors and their advancements.
Undeniably, this was a high-profile, high-level, and high-quality academic event. SpaceGen, with its outstanding product quality and comprehensive end-to-end service system, garnered significant attention and recognition from the experts, pathology teachers, and medical friends present.
PART.3
The 8th International Conference on Clinical and Pathological Advances in Endometrial Disorders
On December 16, 2023, with clear skies after the snowfall, the 8th International Conference on Clinical and Pathological Advances in Endometrial Disorders was successfully held in Xi'an, Shaanxi Province, using a combination of online and offline formats. The conference was jointly organized by the Women's Endocrine Committee of the Shaanxi Sexology Society and the Women's Oncology Committee of the Shaanxi Sexology Society, with the Department of Obstetrics and Gynecology at the First Affiliated Hospital of Xi'an Jiaotong University as the host. The conference featured numerous well-known domestic and international experts who engaged in in-depth discussions on various topics related to endometrial cancer, including molecular subtypes, surgical treatments, diagnosis and treatment of recurrent cases, assessment and treatment methods for preserving fertility, as well as exploring new developments in endometrial cancer screening and the application of artificial intelligence in the diagnosis of endometrial cancer.
In this exhibition, SpaceGen showcased its full range of gynecological tumor gene detection products, attracting numerous exhibitors for communication, discussion, and collaboration. Agreements were reached in multiple specific fields, forming initial intentions for cooperation.
PART.4
Wuhan University People's Hospital Gynecological Tumor Precision Treatment Workshop
The Wuhan University People's Hospital Gynecological Tumor Precision Treatment Workshop was successfully held on December 16, 2023. The conference, grounded in clinical realities and keeping pace with academic frontiers, aims to provide a platform for the exchange of cutting-edge knowledge and clinical experience among colleagues in the field of gynecology at Wuhan University People's Hospital, supporting the standardized diagnosis and treatment of gynecological tumors.
Translated into English:
Invited by SpaceGen, Professor Shen Fujin, Director of the Third Department of Obstetrics and Gynecology at Wuhan University People's Hospital, gave a wonderful lecture on "Ovarian Cancer Gene Testing," attracting high attention.
PART.5
On December 24, the Inspection Department of the First Hospital of Handan City successfully hosted the 2023 Annual Meeting of the Handan Medical Inspection Branch and the Academic Exchange Meeting on the Diagnosis and Clinical Study of Infectious Diseases Laboratory. This event aimed to further enhance the level of new technologies in the field of medical inspection, actively explore the high-quality development of medical inspection under new circumstances.
SpaceGen, as a leading domestic molecular diagnostics company, was invited to lecture on the clinical application of high-throughput sequencing in the genetic testing of lung cancer.
In the future, SpaceGen will continue to bring more new products and technologies to everyone. Stay tuned for updates! For more information, please visit SpaceGen's official website at www.ispacegen.com or follow our WeChat subscription account 'SpaceGen.'
Xiamen SpaceGen Co., Ltd.
Benefiting Public Health
Xiamen SpaceGen Co., Ltd. was established in 2015 and is a national high-tech enterprise settled in Xiamen under the city's "Double Hundred Plans" leading entrepreneurial talent. The company relies on four core technology platforms: high-throughput sequencing (NGS), digital PCR, fluorescence quantitative PCR, and nucleic acid mass spectrometry. It is dedicated to providing comprehensive solutions for personalized and precise diagnosis of tumors, including early screening, disease diagnosis, personalized drug guidance, and efficacy monitoring. The company currently has two medical testing laboratories: Xiamen Spaceseq Medlab and Suzhou Spaceseq Medlab, along with a 3500m² GMP production workshop and a 2000m² research/quality control laboratory. The quality management system has obtained TUV SUD ISO13485 certification. SpaceGen has developed more than 40 products, with three products obtaining National Medical Products Administration (NMPA) Class III medical device registration certificates, 10 products completing Class I medical device filing, and 22 products obtaining EU CE-IVD certification.